the syncytiotrophoblast is a multinucleated layer that plays a critical role in regulating functions of the human placenta during pregnancy. Maintaining the syncytiotrophoblast layer relies on ongoing fusion of mononuclear cytotrophoblasts throughout pregnancy, and errors in this fusion process are associated with complications such as preeclampsia. While biochemical factors are known to drive fusion, the role of disease-specific extracellular biophysical cues remains undefined. Since substrate mechanics play a crucial role in several diseases, and preeclampsia is associated with placental stiffening, we hypothesize that trophoblast fusion is mechanically regulated by substrate stiffness. We developed stiffness-tunable polyacrylamide substrate formulations that match the linear elasticity of placental tissue in normal and disease conditions, and evaluated trophoblast morphology, fusion, and function on these surfaces. our results demonstrate that morphology, fusion, and hormone release is mechanically-regulated via myosin-ii; optimal on substrates that match healthy placental tissue stiffness; and dysregulated on disease-like and supraphysiologically-stiff substrates. We further demonstrate that stiff regions in heterogeneous substrates provide dominant physical cues that inhibit fusion, suggesting that even focal tissue stiffening limits widespread trophoblast fusion and tissue function. These results confirm that mechanical microenvironmental cues influence fusion in the placenta, provide critical information needed to engineer better in vitro models for placental disease, and may ultimately be used to develop novel mechanically-mediated therapeutic strategies to resolve fusion-related disorders during pregnancy. The human placental barrier is responsible for several critical functions during pregnancy including nutrient transport, gas exchange, waste elimination and hormone secretion 1. The placenta hence directly impacts fetal development 2 , immune tolerance 3 , and gestational length 4 , each of which can profoundly affect long-term quality of life and healthcare economics for both mother and baby 5-8. Transport across this fetal-maternal interface is regulated by the syncytiotrophoblast, a multinucleated layer that forms the outer surface of the placental villi 9. The syncytiotrophoblast arises and is maintained by continuous fusion of mononuclear villous cytotrophoblasts (vCTBs) 10 , through a tightly regulated process that can only be partially recreated in vitro 11. Disruption of fusion results in placental malformation and aberrant villous trophoblast turnover 10 , which is associated with life-altering pregnancy complications such as preeclampsia 12 and intrauterine growth restriction 13. Several biochemical factors are known to regulate placental trophoblast fusion in vitro and in vivo, including growth factors 14-16 , hormones 17 , proteases 18-20 , transcription factors 21 and membrane proteins 22. Despite this wealth of information, fusion remains a stochastic and poorly controlled process in cult...